Company intelligence
BriaCell Therapeutics Corp.
Developing Novel Therapies to Destroy Cancer
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.
Verified activity
Signals from BriaCell Therapeutics Corp.
12 published signals
Research & Knowledge
BriaCell Therapeutics Corp. welcomed MSK as a clinical site in its Phase 3 study for metastatic breast cancer.
Reported by BriaCell Therapeutics Corp.
Research & Knowledge
BriaCell Therapeutics Corp. announced that Memorial Sloan Kettering Cancer Center (MSK) joined BriaCell's ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Scientist/Senior Scientist in the Quality Control department in Philadelphia, USA.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Scientist in the Translational Biomarkers and Immunomonitoring department.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Clinical Research Associate Intern.
Reported by BriaCell Therapeutics Corp.
Research & Knowledge
BriaCell Therapeutics Corp. CEO William V. Williams, MD, FACP, discussed the path to personalized scalable solid tumor immunotherapies in a guest column for Drug Discovery Online.
Reported by BriaCell Therapeutics Corp.
Research & Knowledge
BriaCell Therapeutics Corp. highlighted its personalized whole cell melanoma immunotherapy vaccine candidate Bria-MEL+ alongside its Phase 3 trial of Bria-IMT in metastatic breast cancer and Bria-PROS+ in prostate cancer in an Inside Precision Medicine article.
Reported by BriaCell Therapeutics Corp.
Research & Knowledge
BriaCell Therapeutics Corp. President and CEO William V. Williams examined the innovation gap in oncology and the need for scalable approaches to cellular immunotherapy in a new article published in Pharmaphorum.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Scientist/Senior Scientist in the Quality Control department in Philadelphia, USA.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Scientist in Translational Biomarkers and Immunomonitoring.
Reported by BriaCell Therapeutics Corp.
People
BriaCell Therapeutics Corp. is hiring a Clinical Research Associate Intern.
Reported by BriaCell Therapeutics Corp.
Legal & Regulatory
BriaCell Therapeutics Corp. received FDA clearance of its IND application for Bria-PROS+™, initiating a Phase 1/2a clinical trial.
Reported by BriaCell Therapeutics Corp.